Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
HighTide Therapeutics Raises $107 Million in Series Financing to Advance Innovative Pipeline and Business Collaborations
HighTide Therapeutics, a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and […]
Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital
Onc.AI, a medical technology company developing a novel digital clinical management solution focused on immuno-oncology, […]
Actimed Therapeutics Closes Second Tranche of £10m Seed Financing
Actimed Therapeutics, a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to […]
PVmed Raises US $14 Million Series A Funding
Perception Vision Medical Technologies (PVmed), a global artificial intelligence (AI) cancer treatment company, headquartered in […]
Anocca Secures €25 Million from the European Investment Bank to Support Development of T-cell Therapies for Cancer
Anocca, a fully integrated cell therapy biotechnology company, has announced that it has secured €25 […]
Biomica Raises $20 Million in a Funding Round to Advance its Pipeline of Microbiome-based Therapeutics
Biomica, a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene, has […]
Drug Safety Prediction AI Startup Quris Earns Additional Seed Funding Led by SoftBank Vision Fund 2
Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, has announced it has secured […]
Trinity Capital Provides $25 Million Growth Capital To RxAnte
Trinity Capital, a leading provider of diversified financial solutions to growth-stage companies, has announced a […]
Gilgamesh Pharmaceuticals Raises $39 Million in Series B Funding to Advance Mental Health Treatments
Gilgamesh Pharmaceuticals, a biotechnology company developing a portfolio of rapid-acting and durable treatments for depression […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more